Ontology analysis of the genes that were expressed at significantly different levels between all 35 patients, or the subgroups consisting of 20 IFNhigh and 15 IFNlow patients, and healthy controls
| All patients | IFNhigh | IFNlow | |
|---|---|---|---|
| Biological process | p Value | p Value | p Value |
| NS, nonsignificant. | |||
| Processes with a p value <0.05 were considered significant (with Bonferroni correction). | |||
| Immunity and defence | 1.61E−11 | 3.41E−15 | NS |
| Interferon-mediated immunity | 1.09E−06 | 3.38E−08 | NS |
| Macrophage-mediated immunity | 6.83E−05 | 1.27E−04 | NS |
| Lipid and fatty acid transport | 1.54E−04 | NS | NS |
| Transport | 4.82E−04 | 3.33E−02 | NS |
| Cytokine/chemokine-mediated immunity | 1.63E−03 | 2.61E−05 | NS |
| Ligand-mediated signalling | 3.52E−03 | 1.92E−02 | NS |
| Cell motility | NS | 4.24E−03 | NS |
| Blood clotting | NS | 5.30E−03 | NS |
| Oncogenesis | NS | 1.04E−02 | NS |
| Cell structure and motility | NS | 1.55E−02 | NS |
| Inhibition of apoptosis | NS | 1.66E−02 | NS |
| Signal transduction | NS | 3.21E−02 | NS |
| Proteolysis | NS | 3.97E−02 | NS |